It is a mixture of 50% intermediate-acting insulin (isophane) and 50% short-acting insulin (regular). It starts to work as quickly as regular insulin but lasts longer. This insulin product works by helping blood sugar (glucose) get into cells so your body can use it for energy. This ...
NPH insulin has a slower onset time compared to regular insulin. (与普通胰岛素相比,NPH胰岛素的起效时间较慢。) Twice-daily injections of NPH insulin are often recommended for patients with type 2 diabetes. (对于2型糖尿病患者,通常建议每天注射两次NPH胰岛素。) 2. 在医学...
Association redetection of Regular insulin and NPH insulin using statistical featuresdoi:10.1109/sysmart.2016.7894490Anupriya K. KambleRamesh R. ManzaYogesh M. RajputShaikh Abdul HannanInternational Conference System Modeling & Advancement Research Trends...
The potential benefits of rapid-acting insulin analogs versus regular human insulin are that the analogs have earlier onset and peak of biologic activity, resulting in lower postprandial glucose levels; a shorter duration of action, resulting in less late-prandial hypoglycemia; and less biologic variab...
;long-acting —insulina de acción prolongada;NPH —insulina NPH;pre-mixed —insulina premezclada;rapid-acting —insulina de acción rápida;rapid-acting — analogueanálogo de insulina de acción rápida;recombinant —insulina recombinante;regular —insulina regular;to take —inyectarse insulina...
The time course of action of regular and NPH insulins injected sc was studied in 15 insulin-treated diabetics over a 24-h period during which they received a constant infusion of glucose. The blood glucose began to decline in 1.2 +/- 0.1 h (range, 0.5--2) and reached its nadir in ...
Body weight (adjusted for baseline and change in HbA1c) was 1kg lower with insulin detemir/insulin aspart than with NPH insulin/regular human insulin (p<0.001).#Basal-bolus therapy using insulin detemir/insulin aspart offers a better balance of control and tolerability than with NPH insulin/...
Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia 2004; 47: 622- 629.Hermansen K, Fontaine P, Kukolja KK, et al. Insulin analogues (insulin ...
the trial was to compare the efficacy and tolerability of two types of basal-bolus therapy, using either the soluble long-acting basal insulin analogue, insulin detemir, in combination with the rapid-acting analogue, insulin aspart, or NPH insulin in combination with mealtime regular human insulin...
(mostly premix insulin) used in many low-and-middle income countries on glycemic control of children and adolescents with diabetes. The aim of this study was to assess the efficacy of the premix insulin on the glycated hemoglobin (HbA1c) in comparison to the regular with NPH insulin scheme. ...